These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 24054501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
    Lee YL, Lee YJ, Ahn SJ, Choi TH, Moon BS, Cheon GJ, Lee SW, Ahn BC, Ha JH, Lee J.
    Cancer Lett; 2010 Apr 01; 290(1):129-38. PubMed ID: 19819065
    [Abstract] [Full Text] [Related]

  • 3. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE, Yu HM, Liu RS, Lin M, Gelovani JG, Hwang JJ, Wei HJ, Deng WP.
    J Nucl Med; 2006 Jul 01; 47(7):1161-71. PubMed ID: 16818951
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Radiochemotherapy of hepatocarcinoma via lentivirus-mediated transfer of human sodium iodide symporter gene and herpes simplex virus thymidine kinase gene.
    Chen L, Guo G, Liu T, Guo L, Zhu R.
    Nucl Med Biol; 2011 Jul 01; 38(5):757-63. PubMed ID: 21718951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK, Yang DH, Tang SH, Huang W, Lu XH.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):106-10. PubMed ID: 16620715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y, Deb NJ, Garg M, Kabarriti R, Alfieri A, Takahashi M, Roy-Chowdhury J, Guha C.
    Radiat Res; 2014 Aug 10; 182(2):191-200. PubMed ID: 24972258
    [Abstract] [Full Text] [Related]

  • 10. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.
    Liu X, Wang S, Guo X, Wei F, Yin J, Zang Y, Li N, Chen D.
    Oncotarget; 2016 Apr 05; 7(14):18896-905. PubMed ID: 26934443
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.
    Li LQ, Shen F, Xu XY, Zhang H, Yang XF, Liu WG.
    ScientificWorldJournal; 2013 Apr 05; 2013():951343. PubMed ID: 23533367
    [Abstract] [Full Text] [Related]

  • 12. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J, Degrève B, Andrei G, Neyts J, Sandvold M, Myhren F, de Clercq E.
    Gene Ther; 1998 Mar 05; 5(3):419-26. PubMed ID: 9614564
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A new acycloguanosine-specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and suicide gene therapy for potential use in patients treated with pyrimidine-based cytotoxic drugs.
    Likar Y, Dobrenkov K, Olszewska M, Vider E, Shenker L, Cai S, Pillarsetty N, Hricak H, Ponomarev V.
    J Nucl Med; 2008 May 05; 49(5):713-20. PubMed ID: 18413388
    [Abstract] [Full Text] [Related]

  • 15. The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
    Choi Y, Lee HW, Lee J, Jeon YH.
    BMC Cancer; 2013 Mar 22; 13():143. PubMed ID: 23522027
    [Abstract] [Full Text] [Related]

  • 16. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
    Kang Y, Xu CJ, Liu XS, Wu CQ, Zhong CP, Gu JR.
    Ai Zheng; 2005 Aug 22; 24(8):909-14. PubMed ID: 16086864
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
    Tang Q, Lu M, Chen D, Liu P.
    Int J Nanomedicine; 2015 Aug 22; 10():7129-43. PubMed ID: 26604760
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.